Bernard Hockings
Follow
Get notifications in MyBN when activity occurs.
Bernard Hockings
Beneficiary / B Hockings Superannuation Fund
Dr Bernard Hockings was an interventional cardiologist and Clinical Associate Professor in Medicine at the University of Western Australia.
Past appointments included director of the Coronary Care Unit at Royal Perth Hospital, chair of the Medical Advisory Committee Mount Hospital, director of the Cardiac Catheterisation Laboratory St John of God Hospital Bunbury and Health Reserves (WA) for the Royal Australian Air Force.
Dr Hockings had also served on the board of the WA branch of the National Heart Foundation.
Dr Hockings has a lifelong interest in medical research. His doctoral thesis concerned vasodilator therapy in the treatment of heart failure. He is a major shareholder in Phylogica.
Past appointments included director of the Coronary Care Unit at Royal Perth Hospital, chair of the Medical Advisory Committee Mount Hospital, director of the Cardiac Catheterisation Laboratory St John of God Hospital Bunbury and Health Reserves (WA) for the Royal Australian Air Force.
Dr Hockings had also served on the board of the WA branch of the National Heart Foundation.
Dr Hockings has a lifelong interest in medical research. His doctoral thesis concerned vasodilator therapy in the treatment of heart failure. He is a major shareholder in Phylogica.
Lists and Charts
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEWS: Tagged in Iron ore, property drive wealth for state’s highest flyers | 16 Dec 2020 |
| REMUNERATION UPDATE: Non-Executive Director, PYC Therapeutics | 02 Nov 2020 |
| REMUNERATION UPDATE: Non-Executive Director, PYC Therapeutics | 24 Aug 2020 |
| REMUNERATION UPDATE: Non-Executive Director, PYC Therapeutics | 30 Jun 2020 |
News Articles
Related Information
Positions - Current
| Position | Company | Year | Company's current rank | WA staff |
|---|---|---|---|---|
| Beneficiary | |
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Non-Executive Director | | 2014 - 2021 | 87 |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| PYC Therapeutics | 28 Oct 2020 | Issued | 900,000 | $0.17 | $153,000 | Rights issue |
| PYC Therapeutics | 28 Oct 2020 | Issued | 2,041,177 | $0.17 | $347,000 | Rights issue |
| PYC Therapeutics | 15 Jun 2020 | Sold | 87,900,000 | $0.08 | $7,032,000 | Off-market trade |
| PYC Therapeutics | 25 Nov 2019 | Issued | 302,052 | $0.05 | $16,612 | Rights issue |
| PYC Therapeutics | 30 Nov 2018 | Bought | 33,333,334 | $0.03 | $1,000,000 | Placement |
Powered by Morningstar ®
